Why a Peninsula biotech company is targeting a $345M raise. Hint: It has something to do with an aggressive eye cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results